This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet (THC) Up 16.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Inaugurates New Hospital in Florida
by Zacks Equity Research
Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.
Acadia Healthcare (ACHC) Eyes Over 600 Bed Additions in 2022
by Zacks Equity Research
Acadia Healthcare (ACHC) has two de novo projects in Chicago and Indio, CA, which are expected to add a total of around 140 beds this year.
Zacks Investment Ideas feature highlights: Tenet Healthcare and HCA Healthcare
by Zacks Equity Research
Tenet Healthcare and HCA Healthcare are included in this blog.
4 Stocks to Watch From the Flourishing Hospital Industry
by Kaibalya Pravo Dey
Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.
Hospital Stocks Hovering Near 52-Week Highs Despite Market Volatility
by Bryan Hayes
Hospital Stocks Hovering Near 52-Week Highs Despite Market Volatility
Ensign Group (ENSG) on Buyout Binge for Portfolio Boost
by Zacks Equity Research
Ensign Group (ENSG) buys facilities to expand its presence in Arizona and Texas.
Tenet Healthcare (THC) Drops Plans to Spin Off Conifer Segment
by Zacks Equity Research
Tenet Healthcare (THC) aborts its Conifer spin-off plan based on its solid business opportunities and strong pipeline prospects. It also reaffirmed its 2022 guidance.
Acadia Healthcare (ACHC) Q4 Earnings Miss on High Operating Costs
by Zacks Equity Research
Acadia Healthcare (ACHC) anticipates earnings per share within 62-66 cents for the March quarter of 2022.
Encompass Health (EHC) Ties Up to Better Serve Florida Residents
by Zacks Equity Research
Encompass Health (EHC) joins forces with Lee Health in a bid to construct two inpatient rehabilitation hospitals in Southwest Florida and deliver better health outcomes across the region.
Universal Health (UHS) Q4 Earnings Beat on Higher Patient Days
by Zacks Equity Research
Universal Health Services (UHS) expects capital expenditures for 2022 to increase from the 2021 level to the range of $950-$1,100 million.
Mednax's (MD) Q4 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.
Community Health's (CYH) Earnings Beat, Improve Y/Y in Q4
by Zacks Equity Research
Community Health's (CYH) fourth-quarter 2021 results gain from better revenues.
Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q4 results reflect higher revenues, partly offset by steep expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q4 results reflect lower expenses and operational efficiency along with a strong contribution from its Ambulatory Care segment.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 73.08% and 2.80%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Buys Facilities to Expand in California
by Zacks Equity Research
Ensign Group (ENSG) further expands in California by purchasing the operations of Arrowhead Springs Healthcare, San Bernardino, CL and Desert Mountain Care Center, Indio, CL.
Tenet Healthcare (THC) Q4 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -2.86% and 2.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Community Health (CYH) Unit Declares Pricing of Senior Notes
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by pricing senior notes to procure funds.
UnitedHealth (UNH) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect higher revenues, driven by segmental contributions, partly offset by steep expenses.
Encompass Health (EHC) Unveils Hospital Plan in Osceola County
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a rehabilitation facility in Osceola County, FL, which aims to facilitate improved rehabilitation services throughout the region.
What's in Store for UnitedHealth Group's (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results are likely to reflect a rise in earnings and revenues on the back of solid segmental contributions.
Ensign Group (ENSG) Buys Nursing Facility to Expand in Arizona
by Zacks Equity Research
Ensign Group (ENSG) acquires operations of Estrella Health and Rehabilitation Center in Arizona to grow its portfolio and boost U.S. presence.
HCA Healthcare (HCA) Arm Opens Hospital to Aid Florida Presence
by Zacks Equity Research
HCA Healthcare's (HCA) West Florida Division opens Hospital for Endocrine Surgery to boost portfolio and establish further dominance in the state.